Catabasis Pharmaceuticals: My Long Thesis And Analysis Seeking Alpha, 16 Jan 2019 Catabasis Pharmaceuticals (NASDAQ:CATB) recently performed a 10 for 1 reverse stock-split "R/S"; which reduced the number of…